Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].

Rubio-Rivas, ManuelCorbella, XavierGuillén-Del-Castillo, AlfredoTolosa Vilella, CarlesColunga Argüelles, DoloresArgibay, AnaVargas Hitos, José AntonioTodolí Parra, José AntonioGonzález-Echávarri, CristinaOrtego-Centeno, NorbertoTrapiella Martínez, LuisRodríguez Carballeira, MónicaMarín Ballvé, AdelaPla Salas, XavierPerales Fraile, IsabelChamorro, Antonio-JMadroñero Vuelta, Ana BelénFreire, MaykaRuiz Muñoz, ManuelGonzález García, AndrésPons Martín Del Campo, IsaacSánchez García, María EstherBernal Bello, DavidEspinosa, GerardGarcía Hernández, Francisco JoséSáez Comet, LuisRíos Blanco, Juan JoséFernández de la Puebla Giménez, Rafael ÁngelSánchez Trigo, SabelaFonollosa Pla, VicentSimeón Aznar, Carmen PilarRESCLE investigatorsAutoimmune Diseases Study Group (GEAS)2025-01-072025-01-072021-03-22https://hdl.handle.net/10668/26201enCorrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].research article3376661510.1016/j.autrev.2021.1027931873-0183